Now, Bentley is taking its turn at badge redesign, and it's arguably one of the more interesting takes. It's More Than A ...

Bentley updated its iconic 'Winged B' logo for 2025. We take a look back at how the iconic emblem has evolved.

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to HIV-prevention infrastructure in the U.S.

Lipid nanoparticles have emerged as critical platforms for drug and gene delivery, with the success of mRNA COVID-19 vaccines highlighting their potential. Yet our understanding of how to deliver ...

The specific findings of the FDA’s latest inspection of the Sun plant conducted this month have not yet been made public, and the company did not respond to a request for comment. To some current and ...

FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.

Researchers from the George Washington University have uncovered promising evidence in an animal study that shows setmelanotide, an FDA-approved medication for a rare genetic obesity disorder, may ...

(Reuters) -The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for a drug ...

An Egg Harbor Township man who used a township home and another in Atlantic City to distribute drugs two years ago was sentenced Monday to five years in prison.

Recent modifications to FDA’s import alerts, as posted by the agency, are listed below. Click here to go to the FDA page with links to details on specific alerts. See chart below for list of alerts.

Tamarack Biotics secured U.S. FDA acceptance for its novel light-based milk treatment process. This clears the way for a new generation of dairy products that retain the full bioactive benefits of raw ...

The agency claims that since testing began in January, FDA staff have used the tool thousands of times. However, internal confidence in Elsa falls short of the agency's claims.